who should not take retatrutide Gwyneth Paltrow, Andrew Huberman & Who Should Not Take Retatrutide?
Description
36 pounds
Concomitantly, mean systolic blood pressure declines by 35 mmHg, with modest LDL improvements, providing biologically plausible support for downstream cardiovascular risk reduction
The expanding role of GLP-1 medications beyond weight loss, such as their potential to treat conditions like sleep apnea or chronic heart failure, represents an exciting shift in healthcare
Broader immune-mediated reactions may develop weeks later or after dose escalation
More recently, a 2024 cohort study looked at electronic health record data for 18,386 people who were taking one of the medications between May 2022 and September 2023
